Common Stock, Shares, Outstanding of BioCrude Technologies USA, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BioCrude Technologies USA, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • BioCrude Technologies USA, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 50,854,726, a 0.01% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BioCrude Technologies USA, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,854,726 +4,070 +0.01% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 50,854,726 +4,070 +0.01% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 50,854,726 +4,070 +0.01% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 50,854,726 +53,965 +0.11% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 50,850,656 +49,895 +0.1% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 50,850,656 +61,395 +0.12% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 50,850,656 +83,395 +0.16% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 50,800,761 +39,125 +0.08% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 50,800,761 +55,625 +0.11% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 50,789,261 +66,375 +0.13% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 50,767,261 +44,375 +0.09% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 50,761,636 +51,250 +0.1% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 50,745,136 +34,750 +0.07% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 50,722,886 +12,500 +0.02% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 50,722,886 +42,500 +0.08% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 50,710,386 +89,050 +0.18% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 50,710,386 +163,050 +0.32% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 50,710,386 +216,550 +0.43% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 50,680,386 +186,550 +0.37% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 50,621,336 +137,500 +0.27% 31 Dec 2020 10-K 23 Mar 2022 2022 FY
Q3 2020 50,547,336 +63,500 +0.13% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 50,493,836 +63,096 +0.12% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 50,493,836 +63,494 +0.13% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 50,483,836 +53,494 +0.11% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 50,483,836 +58,829 +0.12% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 50,430,740 +8,733 +0.02% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 50,430,342 +14,396 +0.03% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 50,430,342 +375,699 +0.75% 31 Dec 2018 10-K 20 Mar 2020 2019 FY
Q3 2018 50,425,007 +457,448 +0.92% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 50,422,007 +614,554 +1.2% 30 Jun 2018 10-Q 24 Aug 2018 2018 Q2
Q1 2018 50,415,946 31 Mar 2018 10-Q 16 May 2018 2018 Q1
Q4 2017 50,054,643 +546,540 +1.1% 31 Dec 2017 10-K 17 Apr 2019 2018 FY
Q3 2017 49,967,559 30 Sep 2017 10-Q 24 Oct 2017 2017 Q3
Q2 2017 49,807,453 30 Jun 2017 10-Q 12 Sep 2017 2017 Q2
Q4 2016 49,508,103 31 Dec 2016 10-K/A 02 Nov 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.